Anika Therapeutics Inc.

15.02
-0.01 (-0.07%)
At close: Apr 01, 2025, 3:59 PM
15.03
0.10%
After-hours: Apr 01, 2025, 04:20 PM EDT

Anika Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 55.63M 72.87M 86.33M 94.39M 95.82M
Short-Term Investments n/a n/a n/a n/a 2.5M
Long-Term Investments n/a n/a n/a -17.77M -15.68M
Other Long-Term Assets 13.62M 18.67M 17.22M 20.29M 15.42M
Receivables 23.59M 35.96M 34.63M 29.84M 24.1M
Inventory 23.81M 46.39M 39.77M 36.01M 46.21M
Other Current Assets 10.62M 8.1M 8.83M 8.29M n/a
Total Current Assets 113.65M 163.31M 169.55M 168.53M 177.38M
Property-Plant & Equipment 64.68M 74.97M 78.97M 68.56M 73.23M
Goodwill & Intangibles 9.62M 12.2M 81.94M 90.16M 99.57M
Total Long-Term Assets 89.09M 107.32M 179.58M 179.01M 188.22M
Total Assets 202.74M 270.63M 349.13M 347.54M 365.61M
Account Payables 5.62M 9.86M 9.07M 7.63M 8.98M
Deferred Revenue n/a n/a n/a 16.13M 13.21M
Short-Term Debt n/a n/a n/a n/a n/a
Other Current Liabilities 12.23M 3.14M 5.46M 4.32M 13.09M
Total Current Liabilities 23.31M 31.06M 27.91M 29.8M 36.87M
Long-Term Debt 24.01M n/a n/a n/a n/a
Other Long-Term Liabilities 1.43M 404K 398K 1.26M 23.56M
Total Long-Term Liabilities 25.45M 27.31M 35.65M 30.66M 56.34M
Total Liabilities 48.75M 58.37M 63.56M 60.45M 93.2M
Total Debt 25.93M 29.04M 30.89M 19.24M 20.88M
Common Stock 144K 147K 146K 144K 143K
Retained Earnings 71.67M 128.05M 210.72M 225.58M 221.44M
Comprehensive Income -6.78M -5.94M -6.44M -5.72M -4.54M
Shareholders Equity 153.99M 212.26M 285.56M 287.08M 272.4M
Total Investments n/a 4.63M n/a -17.77M 2.5M